Elixinol Wellness (Germany) Today
| E8M Stock | EUR 0 0.0005 33.33% |
Performance11 of 100
| Odds Of DistressLess than 20
|
Elixinol Wellness is trading at 0.001 as of the 22nd of November 2024. This is a 33.33 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.001. Elixinol Wellness has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat good performance during the last 90 days. Equity ratings for Elixinol Wellness Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of May 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes industrial hemp-based nutraceutical, dietary supplements, and skincare products in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. The company has 316.27 M outstanding shares. More on Elixinol Wellness Limited
Moving against Elixinol Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Elixinol Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Elixinol Wellness' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Elixinol Wellness or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Oliver Horn |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Elixinol Wellness Limited (E8M) is traded on Frankfurt Exchange in Germany and employs 16 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elixinol Wellness's market, we take the total number of its shares issued and multiply it by Elixinol Wellness's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Elixinol Wellness classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 316.27 M outstanding shares.
Elixinol Wellness Limited has accumulated about 27.74 M in cash with (14.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Elixinol Wellness Probability Of Bankruptcy
Ownership AllocationElixinol Wellness holds a total of 316.27 Million outstanding shares. Elixinol Wellness Limited shows 15.67 percent of its outstanding shares held by insiders and 4.83 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Elixinol Ownership Details
Elixinol Wellness Risk Profiles
Although Elixinol Wellness' alpha and beta are two of the key measurements used to evaluate Elixinol Wellness' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 18.29 | |||
| Semi Deviation | 16.41 | |||
| Standard Deviation | 33.49 | |||
| Variance | 1121.63 |
Elixinol Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Elixinol Wellness without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Elixinol Wellness Corporate Management
Elected by the shareholders, the Elixinol Wellness' board of directors comprises two types of representatives: Elixinol Wellness inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elixinol. The board's role is to monitor Elixinol Wellness' management team and ensure that shareholders' interests are well served. Elixinol Wellness' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elixinol Wellness' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Greg Smith | Global Chief Information Officer | Profile | |
| Kim BradleyWare | Joint Sec | Profile | |
| Glen Zurcher | Account Department | Profile | |
| Paul Benhaim | Non-Executive Chairman of the Board | Profile | |
| Teresa Cleary | Global General Counsel, Company Secretary | Profile |
Other Information on Investing in Elixinol Stock
Elixinol Wellness financial ratios help investors to determine whether Elixinol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elixinol with respect to the benefits of owning Elixinol Wellness security.